These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9480157)

  • 21. Bacterial contamination of platelet concentrates prepared by different methods: results of standardized sterility testing in Germany.
    Walther-Wenke G; Doerner R; Montag T; Greiss O; Hornei B; Knels R; Strobel J; Volkers P; Däubener W;
    Vox Sang; 2006 Apr; 90(3):177-82. PubMed ID: 16507017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Costs and benefits of HIV-1 antibody testing of donated blood.
    Gelles GM
    J Policy Anal Manage; 1993; 12(3):512-31. PubMed ID: 10127358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost containment and simplification in the blood bank.
    Polesky HF
    Clin Lab Med; 1985 Dec; 5(4):793-9. PubMed ID: 4085192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful removal of Chlamydia pneumoniae from plateletpheresis products collected using automated leukoreduction hemapheresis techniques.
    Webley W; Stuart E; Cirino F; Cahill F; Stec T; Andrzejewski C
    J Clin Apher; 2006 Oct; 21(3):195-201. PubMed ID: 16570261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of random versus apheresis platelet concentrates.
    Andreu G; Vasse J; Sandid I; Tardivel R; Semana G
    Transfus Clin Biol; 2007 Dec; 14(6):514-21. PubMed ID: 18417401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donor selection criteria to maximize double platelet products (DPP) by platelet apheresis.
    Wollersheim J; Dautzenberg M; van de Griendt A; Sybesma B
    Transfus Apher Sci; 2006 Apr; 34(2):179-86. PubMed ID: 16574489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
    Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
    Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood collection and transfusion in the United States in 1999.
    Sullivan MT; Wallace EL
    Transfusion; 2005 Feb; 45(2):141-8. PubMed ID: 15660821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Financing in knee arthroplasty: a benchmarking analysis.
    Effenberger H; Rehart S; Zumstein MD; Schuh A
    Arch Orthop Trauma Surg; 2008 Dec; 128(12):1349-56. PubMed ID: 18309508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 3-year analysis of plateletpheresis donor deferral pattern in a tertiary health care institute: assessing the current donor selection criteria in Indian scenario.
    Tondon R; Pandey P; Chaudhry R
    J Clin Apher; 2008; 23(4):123-8. PubMed ID: 18615635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strengthening the service continuum between transfusion providers and suppliers: enhancing the blood services network.
    Sime SL
    Transfusion; 2005 Oct; 45(4 Suppl):206S-23S. PubMed ID: 16181404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening of colorectal cancer.
    Winawer SJ
    Surg Oncol Clin N Am; 2005 Oct; 14(4):699-722. PubMed ID: 16226687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A critical comparison of platelet preparation methods.
    Vassallo RR; Murphy S
    Curr Opin Hematol; 2006 Sep; 13(5):323-30. PubMed ID: 16888436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of thrombocytapheresis on blood rheology in healthy donors: role of nitric oxide.
    Bor-Kucukatay M; Keskin A; Akdam H; Kabukcu-hacioglu S; Erken G; Atsak P; Kucukatay V
    Transfus Apher Sci; 2008 Oct; 39(2):101-8. PubMed ID: 18707921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Assessment of efficacy and economic impact of an influenza vaccination campaign in the personnel of a health care setting].
    Cella MT; Corona G; Tuccillo E; Franco G
    Med Lav; 2005; 96(6):483-9. PubMed ID: 16983973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days.
    Moog R; Fröhlich A; Mayaudon V; Lin L
    J Clin Apher; 2004; 19(4):185-91. PubMed ID: 15597347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost implications of implementation of pathogen-inactivated platelets.
    McCullough J; Goldfinger D; Gorlin J; Riley WJ; Sandhu H; Stowell C; Ward D; Clay M; Pulkrabek S; Chrebtow V; Stassinopoulos A
    Transfusion; 2015 Oct; 55(10):2312-20. PubMed ID: 25989465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Instituting a thawed plasma procedure: it just makes sense and saves cents.
    Wehrli G; Taylor NE; Haines AL; Brady TW; Mintz PD
    Transfusion; 2009 Dec; 49(12):2625-30. PubMed ID: 19682333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The supply of blood and blood products will be improved through a 5-year research program].
    Högman C
    Lakartidningen; 1980 May; 77(21):2043-4. PubMed ID: 7401755
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.